The compliance Leadership Roundtable

Meet the thought leaders, talk to them, and join them in live conversations.

Last updated: 1/8/2025

Edoardo Lazzarini

Former Senior Ethics & Compliance Officer, Southern Europe (Italy, Spain, Portugal)
Haleon | TAKEDA

Read more

Edoardo, formerly a MedTech compliance officer, brings over 25 years of expertise in compliance and transparency. A recognized thought leader, Edoardo has led ethics programs across top pharmaceutical companies and offers strategic insights into Italian compliance practices.

 

Recent Engagements

  • Actively running Discovery Programs with 20 pharmaceutical companies, 10 medical device companies, 3 labs, and 1 cosmetics company.
  • Transparency Reporting Workshop – Milan – December 17, 2024
  • Hands-on Workshop: From Spend to Telematic Register – Milan – November 12, 2024
  • Italian Sunshine Report: Hands-on Workshop by Experts – Milan – October 14, 2024

 

Upcoming Events

Marialaura Boni

Counsel

Osborne Clarke, Italy

Read more

Marialaura Boni has 20+ years’ experience in advising Italian and foreign businesses in their communication and marketing strategies, with a particular focus on anti-bribery and compliance issues, in the Life Sciences and Healthcare industry.

 

Recent Engagements

  • Hands-on Workshop: From Spend to Telematic Register – Milan – November 12, 2024
  • Italian Sunshine Report: Hands-on Workshop by Experts – Milan – October 14, 2024

 

Upcoming Events

Ned Mumtaz

Former Director, Transparency Operations, Commercial and R&D

PFIZER | OTSUKA

Read more

Ned is a global expert in transparency reporting with extensive experience producing high-quality, compliant reports for over 150 international pharmaceutical companies. He has held leadership positions at Pfizer and Otsuka and is renowned for his work in delivering precise and reliable reports.

 

Recent Engagements

  • Transparency Reporting Workshop – Milan – December 17, 2024
  • Hands-on Workshop: From Spend to Telematic Register – Milan – November 12, 2024
  • Italian Sunshine Report: Hands-on Workshop by Experts – Milan – October 14, 2024

 

Upcoming Events

Robert Cursano

Partner
Baker McKenzie
Read more
Roberto, a former administrative officer at the Italian Ministry of Health, is a partner in Baker McKenzie’s Healthcare and Life Science Practice Group in Italy. He focuses on healthcare law and compliance, assisting with tender procedures, negotiating public contracts and litigating before administrative courts.

 

Recent Engagements

  • Transparency Reporting Workshop – Milan – December 17, 2024

 

Upcoming Events

Mauro Teresi

Counsel
Simmons & Simmons
Read more

Mauro specializes in product liability and regulatory compliance for medical devices and medicinal products. He advises on clinical trials, market access, and promotion compliance, while also handling cross-border litigation and arbitration. His expertise spans healthcare, life sciences, automotive, and consumer goods industries.

 

Recent Engagements

  • Italian Sunshine Law: In-Depth Insights – Online – December 13, 2023

 

Upcoming Events

Q1. For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?

For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?

For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?